Trial intelligence / Profile preview

Sildenafil for severe preeclampsia in pregnancy

IRCT20190201042577N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in preeclampsia comparing Sildenafil citrate with Placebo (2 arms). Primary endpoint: Mean pregnancy time from preeclampsia diagnosis to termination of pregnancy. Started Jan 2019; status: completed.

02

Drugs

sildenafil
03

Conditions

preeclampsia

Beyond the preview

Go deeper on IRCT20190201042577N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190201042577N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call